News
Neither CT perfusion nor CT angiography meet the prespecified validation threshold as an ancillary test for death by neurologic criteria in critically ill patients.
Key factors in this growth include increasing organ demand, enhanced preservation outcomes, ageing of donor population, utilisation of marginal organs, regulatory support, increasing investment in ...
GOTHENBURG, SWEDEN / ACCESS Newswire / June 13, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Yesterday, XVIVO received the prestigious Swedish American Chamber of Commerce USA (SACC-USA) ...
Tennessee Donor Services utilizes Paragonix KidneyVault™ Renal Perfusion System in milestone case. WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a leader in organ transplant technologies ...
Paragonix's donor kidney perfusion system completes commercial flight By Conor Hale Mar 3, 2025 12:06pm Paragonix Technologies Organ transplants kidney transplant Devices ...
The KidneyVault Portable Renal Perfusion System received FDA-clearance in October 2024 and is designed for seamless, end-to-end hypothermic perfusion.
WALTHAM, Mass., February 26, 2025--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first donor kidney ...
CHICAGO, Dec. 18, 2024 /PRNewswire/ -- Bridge to Life Ltd., a leader in organ preservation solutions and perfusion technology, has acquired the VitaSmart™ Hypothermic Oxygenated Machine ...
Normothermic perfusion system extends life of organs waiting for transplant. ScienceDaily. Retrieved May 2, 2025 from www.sciencedaily.com / releases / 2024 / 05 / 240516160556.htm.
Normothermic perfusion system extends life of organs waiting for transplant. Michigan Medicine - University of Michigan. Journal Frontiers DOI 10.3389/fcvm.2024.1325169. Keywords ...
In 2008, he became the first patient to receive a set of donor lungs through UHN’s groundbreaking Toronto Ex Vivo Lung Perfusion (EVLP) System – a medical breakthrough developed at Toronto ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results